18F-FDHT

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug Name18F-FDHT

Drug Alias Name[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone PET18F-FDHT

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionPositron-emission tomography enhancersAndrogen Receptor binders

TargetsAndrogen Receptor

Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMemorial Sloan Kettering Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMemorial Sloan Kettering Cancer Center

Active IndicationsN/A

Inactive IndicationsMetastatic breast cancerBreast Neoplasms

Other Information

ATC CodeN/A